# Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

> **NCT00160654** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 251 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00160654
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11-24
- **Primary completion:** 2006-12-12
- **Final completion:** 2006-12-12
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160654, "Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00160654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*